Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Lymphoma × Breast × Clear all

Status

Sponsor Class

OTHER 85 INDUSTRY 29 NIH 11 NETWORK 2 OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 30 Other hematologic neoplasm 8 Plasma cell 7 Gastrointestinal 2 Sarcoma 1 Myeloid 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 Breast 1

Conditions

Breast Neoplasms 242 Triple Negative Breast Neoplasms 17 Neoplasms 8 Motor Activity 8 Breast Cancer Female 8 Lymphedema 7 Breast Cancer Lymphedema 7 Pathologic Complete Response 6 Neoplasm Metastasis 5 Fatigue 5 Colorectal Neoplasms 5 Colonic Neoplasms 5 Pain, Postoperative 4 Pain 4 Stomach Neoplasms 3 Radiodermatitis 3 Hereditary Breast and Ovarian Cancer Syndrome 3 Endometrial Neoplasms 3 Thyroid Neoplasms 2 Seroma 2 Recurrence 2 Radiation Injuries 2 Melanoma 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 HER2-positive Breast Cancer 2 HER2 Positive Metastatic Breast Cancer 2 HER2 Positive Breast Cancer 2 Fatigue Syndrome, Chronic 2 Drug-Related Side Effects and Adverse Reactions 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03062072 2017-04-07

ECHO

National Cancer Center, Korea

BreastGastrointestinalLymphoid

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡